Opening book details…
About this Medicine article
Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE) by Loibl, Sibylle; de la Pena, Lorena; Nekljudova, Valentina; Zardavas, Dimitrios; Michiels, Stefan; Denkert, Carsten; Rezai, Mahdi; Bermejo, Begoña; Untch, Michael; Lee, Soo Chin; Turri, Sabine; Urban, Patrick; Kümmel, Sherko; Steger, Guenther; Gombos, Andrea; Lux, Michael; Piccart, Martine J.; Von Minckwitz, Gunter; Baselga, José; Loi, Sherene is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Loibl, Sibylle; de la Pena, Lorena; Nekljudova, Valentina; Zardavas, Dimitrios; Michiels, Stefan; Denkert, Carsten; Rezai, Mahdi; Bermejo, Begoña; Untch, Michael; Lee, Soo Chin; Turri, Sabine; Urban, Patrick; Kümmel, Sherko; Steger, Guenther; Gombos, Andrea; Lux, Michael; Piccart, Martine J.; Von Minckwitz, Gunter; Baselga, José; Loi, Sherene
- Publisher
- Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 0959-8049)
- Published
- 2017
- Field
- Medicine (Health Sciences)